BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24711443)

  • 1. Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens.
    Brandler TC; Aziz MS; Rosen LM; Bhuiya TA; Yaskiv O
    Cancer Cytopathol; 2014 Jun; 122(6):468-73. PubMed ID: 24711443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of p63, p40, and GATA-binding protein 3 immunohistochemistry in diagnosing micropapillary urothelial carcinoma.
    Lin X; Zhu B; Villa C; Zhong M; Kundu S; Rohan SM; Yang XJ
    Hum Pathol; 2014 Sep; 45(9):1824-9. PubMed ID: 24993315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uroplakin II (UPII), GATA3, and p40 are Highly Sensitive Markers for the Differential Diagnosis of Invasive Urothelial Carcinoma.
    Hoang LL; Tacha D; Bremer RE; Haas TS; Cheng L
    Appl Immunohistochem Mol Morphol; 2015; 23(10):711-6. PubMed ID: 25611245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.
    Gonzalez-Roibon N; Albadine R; Sharma R; Faraj SF; Illei PB; Argani P; Ertoy D; Allaf ME; Netto GJ
    Hum Pathol; 2013 Dec; 44(12):2651-7. PubMed ID: 24071011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.
    Chang A; Amin A; Gabrielson E; Illei P; Roden RB; Sharma R; Epstein JI
    Am J Surg Pathol; 2012 Oct; 36(10):1472-6. PubMed ID: 22982890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung.
    Brown AF; Sirohi D; Fukuoka J; Cagle PT; Policarpio-Nicolas M; Tacha D; Jagirdar J
    Arch Pathol Lab Med; 2013 Sep; 137(9):1274-81. PubMed ID: 23289761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
    Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
    Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
    Shield PW; Papadimos DJ; Walsh MD
    Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra.
    Chaux A; Han JS; Lee S; Gonzalez-Roibon N; Sharma R; Burnett AL; Cubilla AL; Netto GJ
    Hum Pathol; 2013 Dec; 44(12):2760-7. PubMed ID: 24134931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility and pattern of positivity of p40 in the diagnosis of squamous cell carcinoma of the lung by cytology: the first study on fine needle aspiration smears.
    Jain D; Mathur SR; Guleria R; Iyer VK
    Cytopathology; 2014 Oct; 25(5):330-5. PubMed ID: 24128123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma.
    Alomari AK; Glusac EJ; McNiff JM
    J Cutan Pathol; 2014 Nov; 41(11):839-45. PubMed ID: 25263848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract.
    Gulmann C; Paner GP; Parakh RS; Hansel DE; Shen SS; Ro JY; Annaiah C; Lopez-Beltran A; Rao P; Arora K; Cho Y; Herrera-Hernandez L; Alsabeh R; Amin MB
    Hum Pathol; 2013 Feb; 44(2):164-72. PubMed ID: 22995333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can p40 (Polyclonal) Replace p63 (Clone 4A4) in the Cytologic Diagnosis of Pulmonary Non-Small Cell Carcinoma?
    Alexander M; Chiaffarano J; Zhou F; Cangiarella J; Yee-Chang M; Simsir A
    Am J Clin Pathol; 2017 Jun; 147(6):580-588. PubMed ID: 28498881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma.
    Ha Lan TT; Chen SJ; Arps DP; Fullen DR; Patel RM; Siddiqui J; Carskadon S; Palanisamy N; Harms PW
    J Cutan Pathol; 2014 Nov; 41(11):831-8. PubMed ID: 25263756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomorphology of sebaceous carcinoma with analysis of p40 antibody expression.
    Jain D; Mathur SR; Sharma MC; Iyer VK
    Diagn Cytopathol; 2015 Jun; 43(6):456-61. PubMed ID: 25611456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA3 expression in metastatic urothelial carcinoma in fine needle aspiration cell blocks: a review of 25 cases.
    Siddiqui MT; Seydafkan S; Cohen C
    Diagn Cytopathol; 2014 Sep; 42(9):809-15. PubMed ID: 24578300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p40 exhibits better specificity than p63 in distinguishing primary skin adnexal carcinomas from cutaneous metastases.
    Lee JJ; Mochel MC; Piris A; Boussahmain C; Mahalingam M; Hoang MP
    Hum Pathol; 2014 May; 45(5):1078-83. PubMed ID: 24746214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations of P40 and P63 Immunostains in Different Grades of Esophageal Squamous Cell Carcinoma: A Potential Diagnostic Pitfall.
    Chi Z; Balani J; Gopal P; Peng L; Hammer S
    Appl Immunohistochem Mol Morphol; 2021 Oct; 29(9):674-679. PubMed ID: 34061488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ProEx C as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens.
    Moatamed NA; Rao JY; Alexanian S; Cobarrubias M; Levin M; Lu D; Apple SK
    Cancer Cytopathol; 2013 Jun; 121(6):320-8. PubMed ID: 23364848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.